Yi Xiao

8PUBLICATIONS
30CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Predictive and prognostic markersMolecular targetsCancer geneticsRadiation therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Aug 04, 2026
Migration of immune cells in tumors and inflammation: molecular mechanisms and therapeutic targets.

|Mar 11, 2026
Phase separation of DDHD2 remodels lipid metabolism to dictate treatment sensitivity in luminal breast cancer.

Xiao-Hong Ding, Fenfang Chen, Fan Yang

|Mar 06, 2026
Cancer-immunity cycle-based molecular subtypes in breast cancer predict the response to immune checkpoint inhibitors.

Di Shao, Tianjian Yu, Yi Xiao

|Jun 25, 2025
Mobilizing antigen-presenting mast cells in anti-PD-1-refractory triple-negative breast cancer: a phase 2 trial.

Song-Yang Wu, Xi Jin, Yin Liu

|Jan 31, 2025
Copy number amplification of FLAD1 promotes the progression of triple-negative breast cancer through lipid metabolism.

Xiao-Qing Song, Tian-Jian Yu, Yang Ou-Yang

|Aug 26, 2024
Molecular Characterization and Classification of HER2-Positive Breast Cancer Inform Tailored Therapeutic Strategies.

Yu-Wei Li, Lei-Jie Dai, Xiang-Rong Wu

Pageof 2

Frequent Collaborators

8 joint publications

Zhiming Shao

7 joint publications

Yi-Zhou Jiang

2 joint publications

Ding Ma

1 joint publications

Guan-Hua Su